| 7/10/08 - Stonefly Communications Group Wins Assignment with Life Line Screening |
|
Columbus, Ohio – July 10, 2008 – Stonefly Communications Group, an inVentiv Health company (NASDAQ:VTIV) and an insights–driven healthcare advertising agency, recently announced it has won a professional communications assignment with Life Line Screening of America (LLSA), the nation’s leading provider of community–based preventive health screenings. "Life Line Screening has built a solid reputation in the preventive care and early detection sectors of the health care industry," said John Racik, president and CEO of Stonefly Communications Group. "Their mission of creating awareness of undetected health problems through screenings for conditions like stroke, cardiovascular, and osteoporosis, and encouraging individuals to seek follow up care with their physician, is one of the most important steps to living a longer, healthier life. We are eager to put our team's experience and skills to work to help our client achieve their marketing goals." About Life Line Screening Established in 1993, the Cleveland, Ohio–based company is a leading provider of community–based preventive health screenings. Current screenings include screenings for blocked carotid arteries, atrial fibrillation, abdominal aortic aneurysms, peripheral arterial disease and osteoporosis as well as finger–stick blood tests that provide a complete lipid panel, blood glucose, and high sensitivity C-reactive protein. About Stonefly Communications Group Stonefly Communications Group is an insight–focused, marketing, advertising and communications agency dedicated to redefining success for its clients around the world. With a promise to continually innovate, Stonefly's client advisors and creative champions develop actionable strategies that engage audiences with bold strategic, tactical and creative solutions. See how Stonefly can help you BelieveinhealthSM by visiting www.stoneflygroup.com About inVentiv Health inVentiv Health (NASDAQ: VTIV) is the leading provider of commercialization and complementary services to the healthcare industry globally. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 325 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including the top 20 global pharmaceutical manufacturers. For more information, visit www.inventivhealth.com. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors. |